{
    "id": 3789,
    "fullName": "PIK3CA E453K",
    "impact": "missense",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "PIK3CA E453K lies within the C2 PI3K-type domain of the Pik3ca protein (UniProt.org). E453K results in increased phosphorylation of Akt and Mek1/2, enhanced cell survival, and is transforming in culture (PMID: 26627007, PMID: 29533785).",
            "references": [
                {
                    "id": 11238,
                    "pubMedId": 29533785,
                    "title": "Systematic Functional Annotation of Somatic Mutations in Cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29533785"
                },
                {
                    "id": 4255,
                    "pubMedId": 26627007,
                    "title": "Identification of Variant-Specific Functions of PIK3CA by Rapid Phenotyping of Rare Mutations.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26627007"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 5290,
        "geneSymbol": "PIK3CA",
        "terms": [
            "PIK3CA",
            "CLAPO",
            "CLOVE",
            "CWS5",
            "MCAP",
            "MCM",
            "MCMTC",
            "p110-alpha",
            "PI3K",
            "PI3K-alpha"
        ]
    },
    "variant": "E453K",
    "createDate": "03/16/2015",
    "updateDate": "02/07/2020",
    "referenceTranscriptCoordinates": {
        "id": 171711,
        "transcript": "NM_006218",
        "gDna": "chr3:g.179210291G>A",
        "cDna": "c.1357G>A",
        "protein": "p.E453K",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 13999,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, breast cancer cells expressing PIK3CA E453K demonstrated resistance to treatment with Buparlisib (BKM120) in culture (PMID: 29636477).",
            "molecularProfile": {
                "id": 3596,
                "profileName": "PIK3CA E453K"
            },
            "therapy": {
                "id": 680,
                "therapyName": "Buparlisib",
                "synonyms": null
            },
            "indication": {
                "id": 1612,
                "name": "breast cancer",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 11405,
                    "pubMedId": 29636477,
                    "title": "Characterization of PIK3CA and PIK3R1 somatic mutations in Chinese breast cancer patients.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29636477"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 17327,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a Phase I (SWOG S1400B) trial, Taselisib (GDC-0032) treatment did not meet primary endpoint in patients with lung squamous cell carcinoma harboring PIK3CA mutations, a patients harboring PIK3CA E453K did not demonstrated response (PMID: 31158500; NCT02785913).",
            "molecularProfile": {
                "id": 3596,
                "profileName": "PIK3CA E453K"
            },
            "therapy": {
                "id": 1016,
                "therapyName": "Taselisib",
                "synonyms": null
            },
            "indication": {
                "id": 3907,
                "name": "lung squamous cell carcinoma",
                "source": "DOID"
            },
            "responseType": "no benefit",
            "references": [
                {
                    "id": 15376,
                    "pubMedId": 31158500,
                    "title": "SWOG S1400B (NCT02785913), a Phase II Study of GDC-0032 (Taselisib) for Previously Treated PI3K-Positive Patients with Stage IV Squamous Cell Lung Cancer (Lung-MAP Sub-Study).",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/31158500"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 2860,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, AZD5363 inhibited proliferation of the AGS gastric cancer cell line, which has been reported to harbor KRAS G12D and PIK3CA E453K mutations (PMID: 24088382, PMID: 19755509).",
            "molecularProfile": {
                "id": 10717,
                "profileName": "KRAS G12D PIK3CA E453K"
            },
            "therapy": {
                "id": 655,
                "therapyName": "Capivasertib",
                "synonyms": null
            },
            "indication": {
                "id": 10534,
                "name": "stomach cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 1081,
                    "pubMedId": 24088382,
                    "title": "The AKT inhibitor AZD5363 is selectively active in PI3KCA mutant gastric cancer, and sensitizes a patient-derived gastric cancer xenograft model with PTEN loss to Taxotere.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24088382"
                },
                {
                    "id": 3510,
                    "pubMedId": 19755509,
                    "title": "Combination of EGFR and MEK1/2 inhibitor shows synergistic effects by suppressing EGFR/HER3-dependent AKT activation in human gastric cancer cells.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/19755509"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 3596,
            "profileName": "PIK3CA E453K",
            "profileTreatmentApproaches": [
                {
                    "id": 17125,
                    "name": "Akt1 Inhibitor",
                    "profileName": "PIK3CA E453K"
                },
                {
                    "id": 17123,
                    "name": "mTORC1 Inhibitor",
                    "profileName": "PIK3CA E453K"
                },
                {
                    "id": 17121,
                    "name": "PIK3CA inhibitor",
                    "profileName": "PIK3CA E453K"
                },
                {
                    "id": 17124,
                    "name": "PI3K Inhibitor (Pan)",
                    "profileName": "PIK3CA E453K"
                },
                {
                    "id": 17119,
                    "name": "Akt Inhibitor (Pan)",
                    "profileName": "PIK3CA E453K"
                },
                {
                    "id": 17120,
                    "name": "Akt2 Inhibitor",
                    "profileName": "PIK3CA E453K"
                },
                {
                    "id": 17122,
                    "name": "mTORC2 Inhibitor",
                    "profileName": "PIK3CA E453K"
                },
                {
                    "id": 17126,
                    "name": "mTOR Inhibitor",
                    "profileName": "PIK3CA E453K"
                }
            ]
        },
        {
            "id": 10717,
            "profileName": "KRAS G12D PIK3CA E453K",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 171711,
            "transcript": "NM_006218",
            "gDna": "chr3:g.179210291G>A",
            "cDna": "c.1357G>A",
            "protein": "p.E453K",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 171710,
            "transcript": "XM_006713658",
            "gDna": "chr3:g.179210291G>A",
            "cDna": "c.1357G>A",
            "protein": "p.E453K",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 171712,
            "transcript": "XM_011512894",
            "gDna": "chr3:g.179210291G>A",
            "cDna": "c.1357G>A",
            "protein": "p.E453K",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}